ETC
ALT icon

Exchange Traded Concepts’s Altimmune ALT Stock Holding History

Exchange Traded Concepts’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-175,707
Closed -$680K – 1449
2025
Q2 		$680K Buy
175,707
+22,101
+14% +$120K 0.01% 840
2025
Q1 		$768K Sell
153,606
-5,967
-4% -$37.8K 0.01% 696
2024
Q4 		$1.15M Sell
159,573
-57,188
-26% -$437K 0.02% 512
2024
Q3 		$1.33M Buy
216,761
+92,498
+74% +$627K 0.03% 433
2024
Q2 		$826K Buy
+124,263
New +$917K 0.02% 507

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Exchange Traded Concepts's ALT Position: Q3 2025 in Review

Exchange Traded Concepts sold out of Altimmune (ALT) in Q3 2025, closing a stake of 175,707 shares — an estimated $680K sold.

Exchange Traded Concepts first reported a position in ALT in Q2 2024 and held it in 5 quarters. The position peaked at $1.33M in Q3 2024. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Exchange Traded Concepts reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 175,707 Altimmune shares in Q3 2025, an estimated $680K.
  • Exchange Traded Concepts first reported a position in Altimmune in Q2 2024 and held it in 5 quarters.
  • Exchange Traded Concepts's Altimmune position peaked at $1.33M in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Exchange Traded Concepts's 13F filing for Q3 2025, filed 14 Oct 2025.